Swiss National Bank Summit Therapeutics Inc. Transaction History
Swiss National Bank
- $140 Billion
- Q1 2024
A detailed history of Swiss National Bank transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Swiss National Bank holds 275,000 shares of SMMT stock, worth $2.07 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
275,000
Previous 275,000
-0.0%
Holding current value
$2.07 Million
Previous $717,000
58.72%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding SMMT
# of Institutions
107Shares Held
41.3MCall Options Held
103KPut Options Held
29.9K-
Black Rock Inc. New York, NY9.82MShares$74.1 Million0.0% of portfolio
-
State Street Corp Boston, MA8.11MShares$61.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.27MShares$54.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.15MShares$23.8 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL1.07MShares$8.09 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $1.52B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...